Browsing Tag
oncology clinical trials
3 posts
How ALX Oncology Holdings Inc is repositioning its clinical strategy to achieve pivotal trial readiness by end-2026
ALX Oncology outlines its 2026 pivotal trial roadmap as ASPEN-09 expands and $150m funding extends runway. Read what changes next.
Ateganosine Phase 3 marks inflection point for MAIA Biotechnology with 2026 milestones in focus
Find out how MAIA Biotechnology’s Phase 3 ateganosine trial and 2026 milestones could reshape its regulatory path and investor narrative.
Glioblastoma trial for MT027 moves forward as T-MAXIMUM debuts allogeneic cell therapy in CNS
T-MAXIMUM wins FDA clearance for MT027 in glioblastoma. Read how its non-viral, off-the-shelf CAR-T may reshape solid tumor cell therapy development.